Breast Cancer Update for Surgeons A CME Audio Series and Activity

STATEMENT OF NEED/TARGET AUDIENCE

Breast cancer is one of the most rapidly evolving fields in oncology. Published results from a plethora of ongoing clinical trials lead to the continuous emergence of new therapeutic techniques, agents and changes for existing treatments. In order to offer optimal patient care — including the option of clinical trial participation — the practicing breast surgeon must be well informed of these advances. To bridge the gap between research and patient care, Breast Cancer Update for Surgeons utilizes one-on-one discussions with leading breast cancer investigators. By providing access to the latest research developments and expert perspectives, this CME program assists breast surgeons in the formulation of up-to-date clinical management strategies.

GLOBAL LEARNING OBJECTIVES

• Critically evaluate the clinical implications of emerging clinical trial data in breast cancer screening, diagnosis and treatment.
  
• Describe the current guidelines for, and ongoing clinical trials of, local and regional therapy for noninvasive and invasive breast cancer.
  
• Describe and implement an algorithm for HER2 and estrogen receptor testing in the primary breast cancer setting.
  
• Develop and explain a management strategy for local and systemic treatment of breast cancer in the adjuvant, neoadjuvant and recurrent disease settings.
  
• Counsel postmenopausal patients with ER-positive breast cancer about the risks and benefits of adjuvant aromatase inhibitors in the adjuvant and neoadjuvant settings.
  
• Counsel appropriately selected patients about emerging clinical trial data and ongoing trials in the prevention and treatment of noninvasive (DCIS) and invasive breast cancer.
  

PURPOSE OF THIS ISSUE OF BREAST CANCER UPDATE FOR SURGEONS

The purpose of Issue 3 of Breast Cancer Update for Surgeons is to support these global objectives by offering the perspectives of Drs Pierce, Robert, Ravdin and Margolese on the integration of emerging clinical research data into the management of breast cancer.

SPONSORSHIP STATEMENT

Sponsored by Research To Practice.

ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the Accreditation Council for Continuing Medical Education. Research To Practice is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Research To Practice designates this educational activity for a maximum of 3 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

Home · Search